Effects of GSAO on Signaling Proteins in White Blood Cells
Author Information
Author(s): Cadd Verity A, Hogg Philip J, Harris Adrian L, Feller Stephan M
Primary Institution: Cancer Research UK Cell Signalling Group, Weatherall Institute of Molecular Medicine, University of Oxford, UK
Hypothesis
GSAO affects the phosphorylation of signaling proteins in peripheral white blood cells (PWBC).
Conclusion
GSAO's effects on signaling proteins are influenced by serum conditions, with low serum culture not suitable for studying its activity.
Supporting Evidence
- GSAO induces changes in protein phosphorylation in PWBC.
- Low serum conditions are not suitable for studying GSAO activity.
- GSAO affects a smaller subset of proteins in high serum conditions.
- Activation of the MAP kinase Erk2 was observed with GSAO treatment.
- Hic-5 showed a significant mobility shift upon GSAO treatment.
Takeaway
This study looks at how a new cancer drug, GSAO, changes proteins in white blood cells, showing that the environment can change its effects.
Methodology
Peripheral white blood cells from healthy volunteers were isolated and treated with GSAO or a control compound, and changes in protein phosphorylation were analyzed using Western blots.
Limitations
The study's findings may not fully translate to in vivo conditions due to the differences in serum environments.
Participant Demographics
14 healthy volunteers (8 male, 6 female; aged 23-60 years).
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website